Kintor Pharma top-up and block raise $182m
Kintor Pharmaceutical raised HK$1.17bn ($151m) on Wednesday from a top-up share placement, while a co-founder simultaneously trimmed his stake in the company.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: